New site for bioscience businesses
11 June, 2013A new purpose-built technology hub to support emerging high-tech businesses has been established in South Australia.
Applications invited for export awards
11 June, 2013The Australian Export Awards has commenced its 2013 campaign to crown Australia’s exporting success stories.
ResMed files patent suit against Chinese vendor
07 June, 2013 by Dylan Bushell-EmblingResMed (ASX:RMD) has filed a US patent violation lawsuit against Chinese manufacturer BMC and is seeking to have the company added to its pending ITC case.
IP Laws Bill progressed after Productivity Commission Report
06 June, 2013The federal government has moved to amend intellectual property Crown use provisions following recommendations in the Productivity Commission Inquiry Report on the compulsory licensing of patents.
Bioniche signs licensing, funding deal with Paladin
06 June, 2013 by Dylan Bushell-EmblingBioniche (ASX:BNC) has entered a debt refinancing, funding and Urocidin licensing agreement with Canada’s Paladin Labs.
Consegna trials BreatheAssist in athletes
06 June, 2013 by Dylan Bushell-EmblingConsegna (ASX:CGP) said two thirds of athletes trialling the prototype of the sport version of its BreatheAssist device felt they were able to take more air into their lungs.
Mesoblast wins Japanese patent for stem cell platform
05 June, 2013 by Dylan Bushell-EmblingMesoblast (ASX:MSB) has secured a Japanese patent offering broad protection for its MPC adult stem cell platform in the market through to 2025.
FB Rice names Melbourne biotech partners
05 June, 2013 by Dylan Bushell-EmblingAustralian intellectual property advisory firm FB Rice has appointed two new partners for its Melbourne biotechnology and chemistry practice.
ResMed launches online sleep breathing tool
04 June, 2013 by Dylan Bushell-EmblingResMed (ASX:RMD) has launched a new online - and soon mobile - app to help sleep-disordered breathing patients track their therapy progress and set goals.
Immuron to sell Travelan straight to wholesalers
04 June, 2013 by Dylan Bushell-EmblingImmuron (ASX:IMC) has dissolved its relationship with ANZ distributor Takeda and will start selling its flagship Travelan product directly to wholesalers in the markets.
Cochlear shares slump on word of weaker sales
04 June, 2013 by Dylan Bushell-EmblingCochlear Limited (ASX:COH) revealed its 2H sales have been lower as its customers awaited the now-in-process launch of its Nucleus 6 sound management product line.
Manufacturing CRC invites participation
04 June, 2013A new Cooperative Research Centre (CRC) for Manufacturing Industry Innovation (MIICRC) invites organisations to participate as industry partners.
FDA blocks imports of Pharmaxis asthma test
03 June, 2013 by Dylan Bushell-EmblingThe US FDA has added Pharmaxis’s Aridol to its Import Alert list, preventing the company from shipping units of the asthma test into the market.
Another pharma evaluating pSivida’s Durasert
30 May, 2013 by Dylan Bushell-EmblingpSivida (ASX:PVA) has signed an evaluation agreement with an unnamed global pharmaceutical company covering its Durasert ophthalmic insert.
AusBiotech investment summit heading for Melbourne
30 May, 2013Australia Biotech Invest 2013, the largest life science investment meeting in Australia, will this year be held on 28 and 29 October at the Melbourne Convention and Exhibition Centre.
